Liraglutide shows efficacy in boosting liver enzymes in diabetes

12/2/2012 | Modern Medicine

Data from six Liraglutide Effect and Action in Diabetes program trials showed liraglutide and other GLP-1 analogues were safe and effective in improving liver enzymes in overweight type 2 diabetes patients. Liraglutide also fared better than placebo in reducing alanine transaminase levels in patients, researchers wrote in the journal Alimentary Pharmacology and Therapeutics.

View Full Article in:

Modern Medicine

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ